Cargando…

Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2

The receptor binding domain (RBD) of the Spike protein from SARS-CoV-2 is a promising candidate to develop effective COVID-19 vaccines since it can induce potent neutralizing antibodies. We have previously reported the highly efficient production of RBD in Pichia pastoris, which is structurally simi...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758758/ https://www.ncbi.nlm.nih.gov/pubmed/35027583 http://dx.doi.org/10.1038/s41598-021-03675-0

Ejemplares similares

Author Correction: Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2
Publicado: (2022)

Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
por: Bouwman, Kim M., et al.
Publicado: (2021)

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
por: Tan, Tiong Kit, et al.
Publicado: (2021)

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2020)

Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells
Publicado: (2020)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
por: Dokainish, Hisham M, et al.
Publicado: (2022)

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
por: Verma, Saroj, et al.
Publicado: (2022)

Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Mamchur, Aleksandra A., et al.
Publicado: (2022)

Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients
por: Cao, Zhiliang, et al.
Publicado: (2010)

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
por: Sakib, Md Minhas Hossain, et al.
Publicado: (2021)

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
por: Du, Lanying, et al.
Publicado: (2007)

Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice
por: Maharjan, Puna Maya, et al.
Publicado: (2021)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Multimeric single-domain antibody complexes protect against bunyavirus infections
por: Wichgers Schreur, Paul J, et al.
Publicado: (2020)

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
por: Hussain, Arif, et al.
Publicado: (2020)

Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain
por: Barh, Debmalya, et al.
Publicado: (2020)

Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
por: Antonopoulos, Aristotelis, et al.
Publicado: (2020)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)

Insights into the conformation changes of SARS-CoV-2 spike receptor-binding domain on graphene
por: Du, Jianbin, et al.
Publicado: (2022)

The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression
por: Maffei, Mariano, et al.
Publicado: (2021)

A Fungal Defensin Targets the SARS−CoV−2 Spike Receptor−Binding Domain
por: Gao, Bin, et al.
Publicado: (2021)

Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
por: Rodríguez, Yoel, et al.
Publicado: (2022)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
por: Bozdaganyan, Marine E., et al.
Publicado: (2022)

Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein
por: Chukwudozie, Onyeka S., et al.
Publicado: (2021)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
por: Behera, Santosh Kumar, et al.
Publicado: (2021)

Characterization of Phytochemicals in Ulva intestinalis L. and Their Action Against SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
por: Kulkarni, Seema A., et al.
Publicado: (2021)

Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
por: Kim, Young-Il, et al.
Publicado: (2021)

Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets
por: Kim, Young-Il, et al.
Publicado: (2021)

The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
por: Kim, Sinae, et al.
Publicado: (2020)

Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants
por: Hollingsworth, Scott A., et al.
Publicado: (2023)

“Armed for the future Coronavirus pandemic”: a promising use of the multimeric SARS-CoV-2 receptor binding domain nanoparticle as a new Pan-Coronavirus vaccine
por: Kumar, Manoj, et al.
Publicado: (2021)

Binding behavior of spike protein and receptor binding domain of the SARS-CoV-2 virus at different environmental conditions
por: Zhang, Meiyi, et al.
Publicado: (2022)

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qui87gjpic24bio1pqngqnkisi